This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Myokardia, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Amy Sehnert: Innovator in Myosin Modulation
Introduction
Amy Sehnert is a prominent inventor based in Brisbane, California. She has made significant contributions to the field of medical treatments, particularly through her innovative work involving myosin modulators. Her dedication to advancing healthcare solutions is evident in her patent portfolio.
Latest Patents
Amy Sehnert holds a patent for "Methods of treatment with myosin modulator." This patent describes methods of treatment that involve administering a therapeutically effective amount of a myosin modulator or a pharmaceutically acceptable salt thereof to a subject in need. The patent also includes diagnostic methods useful in connection with these treatments. Notably, the treatments can be performed in the absence of beta blocker therapy or with reduced beta blocker therapy.
Career Highlights
Amy is currently associated with Myokardia, Inc., where she continues to work on innovative solutions in the medical field. Her role at the company allows her to collaborate with other experts and contribute to groundbreaking research.
Collaborations
Amy Sehnert has worked alongside Jay M Edelberg, further enhancing her contributions to the field. Their collaboration exemplifies the importance of teamwork in driving innovation.
Conclusion
Amy Sehnert's work in myosin modulation represents a significant advancement in treatment methodologies. Her patent and ongoing contributions to Myokardia, Inc. highlight her commitment to improving patient care through innovative solutions.